Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SimpliiGood is an Israeli biotechnology company focused on the commercial-scale cultivation and processing of fresh spirulina for the food and wellness industries. The company employs a proprietary, fully automated hydroponic system that produces spirulina with a neutral taste and high nutrient bioavailability, distinguishing it from traditional dried algae products. SimpliiGood's innovation extends to the development of plant-based meat alternatives, including a spirulina-derived smoked salmon analog created in collaboration with industry partners. By optimizing the biological potential of cyanobacteria, the company provides sustainable, nutrient-dense protein solutions aimed at addressing global food security and nutritional needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SimpliiGood.